Psilocybe semilanceata

.

.

Scientific America:

"Oregon made history on November 3, becoming not just the first U.S. state to legalize psilocybin, the psychoactive compound in “magic mushrooms,” but also the first jurisdiction in the world to lay out plans for regulating the drug’s therapeutic use.

The next day, on the opposite coast, Johns Hopkins University researchers published results from the first randomized controlled trial of treating major depressive disorder with synthetic psilocybin. 

Their study, published in JAMA Psychiatry, found 71 percent of patients experienced a “clinically significant response” (an improvement that lasted at least four weeks after treatment). 

And 54 percent met the criteria for total “remission of depression.”

(Look at this number and this is from JAMA, a reliable source)

At the U.S. federal level, psilocybin remains a completely prohibited Schedule 1 Drug, defined by the Drug Enforcement Administration as having “no currently accepted medical use and a high potential for abuse.” 

Full article here 

https://apple.news/AZg_BrwYvR22VAeIw_4WGGw